Literature DB >> 8764128

Somatic mutations of the APC gene in sporadic hepatoblastomas.

H Oda1, Y Imai, Y Nakatsuru, J Hata, T Ishikawa.   

Abstract

Hepatoblastoma is a rare hepatic malignancy that occurs in children with an average age of 2 or 3 years and is known to be one of the extracolonic manifestations of familial adenomatous polyposis. Only a single hepatoblastoma with a germ-line mutation of the adenomatous polyposis coli (APC) gene has been reported thus far. To elucidate the possible roles of APC gene alterations in sporadic hepatoblastomas, we examined loss of heterozygosity (LOH) at the APC and MCC loci and performed a sequencing analysis of a part of the APC gene, including the mutation cluster region, in 13 hepatoblastomas of non-familial adenomatous polyposis patients. LOH at the APC and/or MCC loci was observed in four of seven (57%) informative cases. Of the 13 cases, somatic mutations were detected in 8 (61.5%), with 9 (69%) cases showing genetic alterations in the APC gene as LOH or somatic mutations. Two cases demonstrated double mutations. Furthermore, the nature of the somatic mutations observed in the present study was unusual because 9 of the 10 mutations were missense, with only 1 case featuring a frame-shift mutation due to an insertion. Previous reports have described almost all (>90%) mutations of the APC gene in colorectal tumors to result in a truncated APC protein due to either frame-shift or nonsense mutations. These findings suggest that a mutation of the APC gene may play an important role in the genesis of sporadic hepatoblastomas, and the mechanisms of APC gene alteration may be different from those reported previously for colorectal tumors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764128

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Beckwith-Wiedemann syndrome, pancreatoblastoma, and the wnt signaling pathway.

Authors:  Natalie J Kerr; Ryuji Fukuzawa; Anthony E Reeve; Michael J Sullivan; Ryuji Fukazawa
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

2.  Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.

Authors:  R G Weber; T Pietsch; D von Schweinitz; P Lichter
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Wnt/beta-catenin signaling in hepatic organogenesis.

Authors:  Kari Nejak-Bowen; Satdarshan Ps Monga
Journal:  Organogenesis       Date:  2008-04       Impact factor: 2.500

Review 4.  Hypermutability in carcinogenesis.

Authors:  B S Strauss
Journal:  Genetics       Date:  1998-04       Impact factor: 4.562

5.  Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas.

Authors:  S C Abraham; E A Montgomery; F M Giardiello; T T Wu
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 6.  β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis.

Authors:  Satdarshan Pal Monga
Journal:  Gastroenterology       Date:  2015-03-05       Impact factor: 22.682

7.  Avatars to personalized medicine: of mice and men.

Authors:  Matthias Ilmer; Michael Berger
Journal:  Hepatobiliary Surg Nutr       Date:  2017-10       Impact factor: 7.293

8.  Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p.

Authors:  S C Abraham; T T Wu; D S Klimstra; L S Finn; J H Lee; C J Yeo; J L Cameron; R H Hruban
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

9.  Reconstructed beta-catenin/TCF4 signaling in yeast applicable to functional evaluation of APC mutations.

Authors:  Hidehisa Yamada; Keiji Furuuchi; Tetsuya Aoyama; Akihiko Kataoka; Jun-ichi Hamada; Mitsuhiro Tada; Shunichi Okushiba; Satoshi Kondo; Tetsuya Moriuchi; Hiroyuki Katoh
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 10.  Lessons from development: A role for asymmetric stem cell division in cancer.

Authors:  Anne E Powell; Chia-Yi Shung; Katherine W Saylor; Karin A Müllendorff; Karin A Müllendorf; Joseph B Weiss; Melissa H Wong
Journal:  Stem Cell Res       Date:  2009-09-25       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.